摘要
目的 探讨超声对甲状旁腺结节诊断的临床价值。方法 回顾性分析福建省肿瘤医院2007年9月至2023年4月收治住院并经术后病理证实的93例(102个结节)甲状旁腺病变患者的临床资料。结果 102个甲状旁腺结节中,术后病理证实甲状旁腺腺瘤80个(78.43%),甲状旁腺增生15个(14.71%),甲状旁腺囊肿2个(1.96%),甲状旁腺癌5个(4.90%)。超声共检出90个甲状旁腺结节(88.24%),结节多位于甲状腺下部背侧,其中甲状旁腺腺瘤和甲状旁腺增生多呈低回声,边界清,内部回声多为不均匀,血流信号多较丰富;甲状旁腺囊肿则为无回声,边界清楚,内部回声均匀,无明显血流信号;甲状旁腺癌多呈低回声,边界不清,内部回声不均,血流信号较丰富。93例患者术后均行甲状旁腺激素(parathyroid hormone,PTH)检测,除2例转移性甲状旁腺癌为阴性外,其余91例均为阳性。结论 超声对甲状旁腺病变有一定的临床诊断价值。
Objective To investigate the clinical value of ultrasound on parathyroid nodules.Methods A total of 93 patients(102 nodules)with parathyroid lesions admitted to Fujian Cancer Hospital from September 2007 to April 2023 and confirmed by postoperative pathology were retrospectively studied.Results There were 102 nodules in the 93 patients,including 80 parathyroid adenomas(78.43%),15 parathyroid hyperplasias(14.71%),2 parathyroid cysts(1.96%)and 5 parathyroid carcinomas(4.90%).A total of 90 nodules(88.24%)were detected by ultrasound,and most nodules were located on the dorsal side of the lower part of the thyroid gland.Among them,parathyroid adenoma and parathyroid hyperplasia showed low echo,clear boundary,uneven internal echo and abundant blood flow signals.Parathyroid cyst showed no echo,clear boundary,uniform internal echo and no obvious blood flow signal.Parathyroid carcinoma is mostly hypoechoic,with unclear boundary,uneven internal echo and rich blood flow signal.Parathyroid hormone(PTH)detection was performed in all 93 patients after surgery,except for 2 patients with metastatic parathyroid carcinoma,and 91 patients with metastatic parathyroid carcinoma.Conclusion Ultrasound is valuable in clinical diagnosis of parathyroid disease.
作者
林若旋
唐丽娜
黄伟钦
柯晓慧
LIN Ruoxuan;TANG Lina;HUANG Weiqin;KE Xiaohui(Department of Ultrasonography,Clinical Oncology School of Fujian Medical University,Fujian Cancer Hospital,Fuzhou 350014,Fujian,China)
出处
《中国现代医生》
2023年第36期54-57,共4页
China Modern Doctor
基金
福建医科大学启航基金项目(2022QH1162)。
关键词
超声
彩色多普勒
甲状旁腺疾病
诊断
甲状旁腺激素
Ultrasound
Color doppler
Parathyroid diseases
Diagnosis
Parathyroid hormone